EIF5A2 is a novel chemoresistance gene in breast cancer.

CONCLUSION: This study shows that eIF-5A2 plays an important role in doxorubicin chemoresistance in breast cancer cells. PMID: 24638963 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24638963?dopt=Abstract

Source: Breast Cancer - March 18, 2014 Category: Cancer & Oncology Authors: Liu Y, Du F, Chen W, Yao M, Lv K, Fu P Tags: Breast Cancer Source Type: research